Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-710-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Principles of method if other than guideline:
- Not Applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Nickel dihydroxide
- EC Number:
- 235-008-5
- EC Name:
- Nickel dihydroxide
- Cas Number:
- 12054-48-7
- IUPAC Name:
- nickel(2+) dihydroxide
- Details on test material:
- - Name of test material (as cited in study report): Nickel dihydroxide (N106)
- Physical state: solid powder/green
- Active components: >99% nickel dihydroxide
- Stability: stable
- Lot/batch No.: not provided by the study sponsor
- Storage: at room temperature, closed container
Constituent 1
Method
- Target gene:
- TK
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: RPMI 1640 complete medium (see specific descriptions below for culture, treatment and selective medium preparations)
Complete Culture Medium = RPMI 1640 medium supplemented with 15% horse serum, 100U/100 ug/ml Penicillin/Streptomycin, 1mM sodium pyruvate, 2mM L-glutamine, 25 mM HEPES, 250 ug/ml amphotericin B
Treatment Medium = RPMI 1640 medium supplemented with 3% horse serum, 100U/100 ug/ml Penicillin/Streptomycin, 1mM sodium pyruvate, 2mM L-glutamine, 25 mM HEPES, 250 ug/ml amphotericin B
Selective Medium = RPMI 1640 medium supplemented with TFT (5ug/mL)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically "cleansed" against high spontaneous background: yes; stock cultures of the cleansed L5178Y cell line were utilized. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver microsome preparation (S9) from phenobarbital- and beta-naphtoflavone-induced rats
- Test concentrations with justification for top dose:
- The selection of concentrations was based on data from a pre-experiment, which consisted of 6 concentrations (0.5 to 10 mM with and without metabolic activation). Exposure concentrations for the main study were:
With metabolic activation: 2, 3.5, 5, 6, 6.4, 7.6, 8, 8.5 mM
Without metabolic activation: 1, 2, 2.5, 3, 3.5, 4.5, 5, 5.5 mM - Vehicle / solvent:
- Nickel dihydroxide was suspended in cell culture medium (RPMI + 3% HS) and diluted prior to treatment. The solvent was compatible with the survival of the cells and the S9 activity.
Controls
- Untreated negative controls:
- other: solvent used as negative control
- Negative solvent / vehicle controls:
- yes
- Remarks:
- used as negative control
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- three compounds used as positive controls
- Positive control substance:
- other: ethylmethanesulfonate (EMS) and methylmethanesulfonate (MMS) used as positive controls without metabolic activation; benzo[a]pyrene used as positive control with metabolic activation
- Remarks:
- Not Applicable
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: 1 x 10^7 cells/mL (25cm2) flasks) were suspended in 11mL RPMI medium with 3% horse serum and exposed to designated concentrations of the test compound in the presence or absence of metabolic activation
DURATION/NUMBER OF CELLS/REPLICATIONS EVALUATED:
- Exposure duration: 4 hr
- Expression time (cells in growth medium): cells were suspended in 30 mL complete culture medium and incubated for an expression and growth period of 72 hr at 37°C and 5% CO2/95% humidified air. The cell density was determined each day and adjusted to 3 x 10^5 cells/ml if necessary.
- Selection time (if incubation with a selection agent): Cells from each experimental group were seeded in four 96-well plates at a density of approximately 2000 cells/well in 200uL selective medium with TFT. Plates were scored after an incubation period of 11 to 14 days at 37°C in 5% CO2/95% humidified air.
SELECTION AGENT (mutation assays): TFT (5 ug/mL)
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency; following the 72 hr expression time, the relative cloning efficiency (RCE) was determined. Cells were seeded in two 96-well plates, 1.6 cells/well (statistical number), and incubated for 6 days at 37°C in a humidified atmosphere with 5% CO2. Relative suspension and total growth (RSG and RTG; RTG = [RSG x RCE]/100) of the treated cell cultures were calculated according to the method of Clive and Spector.
DETERMINATION OF MUTATION FREQUENCY
Mutation frequencies were calculated from the data obtained from cultures (4 plates/dose group) used for the cloning efficiency (cultures with non selective medium) and those used for selection (cultures with selective medium): mutation frequency = (-ln[NC/TC (selective medium)])/(-ln[NC/TC(non selective medium)]) x 800.
NC: number of negative cultures
TC: total number of cultures seeded
DETERMINATION OF POTENTIAL CLASTOGENIC EFFECTS
Colony sizing was performed for the highest concentrations of the test substance and for the negative and positive controls. A mutation frequency above 2 in combination with an increased occurrence of small colonies (defined by slow growth and/or morphological alteration of the cell clone) indicated by a low large/small colony ratio (ratio of clastogenic controls MMS and/or B[a]P with a coefficient of 1.5), is an indication for potential clastogenic effects and/or chromosomal aberrations. - Evaluation criteria:
- Several criteria were used in determining a positive result:
(1) clear and dose-related increase in the mutant frequncy
(2) biologically relevant response (at least 2-fold increase of mutant frequencies related to the comparable negative control values and higher than the historical range of negative controls) for at least one of the dose groups
(3) combined with a positive effect in the mutant frequncy, an increased occurrence of small colonies (slow growth colonies) indicated by a low large/small colonies ratio (ratio of the clastogenic controls MMS and/or B[a]P with a coefficient of 1.5 is an indication for potential clastogenic effects and/or chromosomal aberrations.
A test item is considered to be negative if there is not biologically relevant increase in the induction of mutant cells above concurrent control levels, at any dose level. - Statistics:
- According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Remarks:
- mutagenic, clastogenic
- Cytotoxicity / choice of top concentrations:
- other: growth inhibition observed
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
Pre-tests for toxicity were conducted. Two negative control (vehicle) groups were tested along with 6 concentrations of the test compund (0.5 to 10 mM, with and without metabolic activation). The relative suspension growth (RSG) was 100% in the control group. For the test compound RSG ranged from 5.19% to 93.68% with metabolic activation (dose-response relationship observed), and from 3.38 to 101.4% without metabolic activation (dose-response relationship observed).
COMPARISON WITH HISTORICAL CONTROL DATA:
Mutant values of the negative controls were within historical control data of the test facility. Mutant values from the two low dose groups with metabolic activation were also within the range of historical control data, though dose groups of 5 mM and higher were outside of the data. Without metabolic activation, mutant values of the dose groups evaluated up to 3mM were within historical data, but above for dose groups from 3.5 mM and higher.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Growth inhibition was observed with and without metabolic activation. The relative total growth (RTG) with metabolic activation ranged from 18.06% to 84.66%; without metabolic activation, the RTG ranged from 14.05% to 86.3%. Dose-response relationships were observed in datasets associated with and without metabolic activation.
POTENIAL FOR CLASTOGENICITY:
A clastogenic effect was observed for the test substance both with and without metabolic activation (see tables below). The positive control compounds induced a significant increase of the mutant frequency and biologically significant increase of small colonies, thus proving the ability of the test system to indicate potential clastogenic effects. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
RESULTS WITH METABOLIC ACTIVATION
Mutagenicity Data with metabolic activation (see Table 4 in study report)
Test Group | Concentration (mM) | RCE (%) | Mean* Number of Cultures/96 wells | Mutants/10^6 cells (Mutation Frequency) | Mutation factor |
NC1 | 0 | 100 | 21.5 | 101.45 | not applicable |
NC2 | 0 | 100 | 22.25 | 119.78 | not applicable |
1 | 2 | 94.15 | 26 | 158.53 | 1.43 |
3 | 3.5 | 101.54 | 29.75 | 151.26 | 1.37 |
6 | 5 | 108.31 | 40.25 | 174.97 | 1.58 |
8 | 6 | 110.77 | 44.5 | 179.69 | 1.62 |
9 | 6.4 | 84.92 | 42.5 | 368.73 | 3.33 |
12 | 7.6 | 92.31 | 46.75 | 351.32 | 3.18 |
13 | 8 | 96.62 | 45.75 | 304.25 | 2.75 |
14 | 8.5 | 102.77 | 51.00 | 297.33 | 2.69 |
B[a}P | 2.5 ug/ml | 108.92 | 54.75 | 265.06 | 2.40 |
*Based on 4 plates
Colony Sizing, with metabolic activation (see Table 5 in study report)
Test Group | Concentration (mM) | Quotient Large/Small |
NC1 | 0 | 1.15 |
NC2 | 0 | 1.70 |
12 | 7.6 | 0.53 |
13 | 8 | 0.54 |
14 | 8.5 | 0.31 |
B[a]P | 2.5 ug/ml | 0.74 |
RESULTS WITHOUT METABOLIC ACTIVATION
Mutagenicity Data without metabolic activation (see Table 7 in study report)
Test Group | Concentration (mM) | RCE (%) | Mean* Number of Cultures/96 wells | Mutants/10^6 cells (Mutation Frequency) | Mutation factor |
NC1 | 0 | 100 | 19 | 71 | not applicable |
NC2 | 0 | 100 | 18.75 | 73.44 | not applicable |
5 | 1 | 100.57 | 18.25 | 67.88 | 0.94 |
7 | 2 | 92 | 20.75 | 106.84 | 1.48 |
9 | 2.5 | 101.14 | 20.25 | 74.34 | 1.03 |
10 | 3 | 101.14 | 24.75 | 93.56 | 1.30 |
11 | 3.5 | 90.29 | 34.75 | 207.67 | 2.88 |
13 | 4.5 | 89.14 | 34 | 208.95 | 2.89 |
14 | 5 | 95.43 | 39.75 | 209.77 | 2.9 |
15 | 5.5 | 96.57 | 41.5 | 213.44 | 2.96 |
EMS | 500 ug/ml | 88.57 | 79.5 | 855.59 | 11.85 |
MMS | 10 ug/ml | 88.57 | 70.75 | 648.87 | 8.98 |
*Based on 4 plates
Colony Sizing, without metabolic activation (see Table 8 in study report)
Test Group | Concentration (mM) | Quotient Large/Small |
NC1 | 0 | 5.33 |
NC2 | 0 | 2.41 |
13 | 4.5 | 0.77 |
14 | 5 | 0.53 |
15 | 5.5 | 0.61 |
MMS | 10 ug/ml | 0.55 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive mutagenic in the mouse lymphoma thymidine kinase locus
The study report concluded that based on the mutagenicity test under the experimental conditions reported, the test item Nickel dihydroxide (N106) is considered to be mutagenic in the mouse lymphoma thymidine kinase locus using the cell line L51787. - Executive summary:
This GLP in vitro mammalian cell gene mutation study was conducted in accordance with OECD Guideline No. 476, EEC Directive Annex 4E, B 17, and EPA OPPTS 870.5300. The mouse lymphoma cell line L5178Y was used to evaluate the potential for Nickel dihydroxide (N106) to induce mutations at the thymidine kinase locus, both in the presence and absence of metabolic activation. Cells were exposed to the test substance (in suspension) for 4 hours; 8 concentrations were used (2, 3.5, 5, 6, 6.4, 7.6, 8, 8.5 mM with metabolic activation and 1, 2, 2.5, 3, 3.5, 4.5, 5, 5.5 mM without metabolic activation; dose selection based on findings from a pre-experiment). EMS and MMS were used as positive controls for studies without metabolic activation, and B[a]P was used in studies with activation. Vehicle exposure served as the negative controls. Following designated expression and selection times, cytotoxicity and mutagenicity were evaluated based on relative total growth (RTG) and mutation frequency, respectively. Growth inhibition was observed with and without metabolic activation in a dose-dependent manner. The relative total growth (RTG) with metabolic activation ranged from 18.06% to 84.66%; without metabolic activation, the RTG ranged from 14.05% to 86.3%. Similarly, an increased mutation frequency was observed; mutation factors ranged from 1.37 to 3.33 with metabolic activation, and 0.94 to 2.96 without metabolic activation. The potential for inducing clastogenic effects was also assessed by comparing the ratios of large to small colonies in the high dose groups. Results indicated the potential for clastogenic effects both with and without metabolic activation. The study report concluded that based on the mutagenicity test under the experimental conditions reported, the test item Nickel dihydroxide (N106) is considered to be mutagenic in the mouse lymphoma thymidine kinase locus using the cell line L51787.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
